The cytotoxic potential of a naturally occurring
indoloquinazoline alkaloid, soyauxinium
chloride (SCHL), was determined on a broad panel of animal and human
cancer cell lines, including various sensitive and
drug-resistant phenotypes. The cytotoxicity, SCHL-induced autophagic, ferroptotic, and necroptotic cell death were evaluated by the
resazurin reduction assay (RRA).
Caspase-Glo assay was used to detect the activity of
caspases using spectrophotometric analysis. Flow cytometry was applied for cell cycle analysis (PI staining), apoptosis (
annexin V/PI staining), mitochondrial membrane potential (
MMP) (JC-1) and
reactive oxygen species (ROS) (H2DCFH-DA). SCHL and
doxorubicin (reference molecule) exhibited cytotoxic effects towards the 18
cancer cell lines tested. The IC50 values obtained ranged from 3.64 μM (towards CCRF-CEM
leukemia cells) to 16.86 μM (against the BRAF-wildtype SKMel-505
melanoma cells for SCHL). Collateral sensitivity of the resistant HCT116 p53-/-
colon adenocarcinoma cells to SCHL was observed as well as the normal sensitivity of CEM/ADR5000
leukemia cells, MDA-MB-231-BCRP breast
adenocarcinoma cells and U87. MGΔEGFR
glioblastoma cells. SCHL induced apoptosis in CCRF-CEM cells via
caspases 3/7-, 8- and 9-activation,
MMP alteration and increased ROS production, and otherwise ferroptosis and necroptosis. SCHL is a prominent cytotoxic
alkaloid that should be further studied to develop a novel
drug to combat
cancers including refractory phenotypes.